Orange Book product · Generic (ANDA)
DORZOLAMIDE HYDROCHLORIDE
DORZOLAMIDE HYDROCHLORIDE
At a glance
Jan 27, 2022
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 27, 2022
4 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
DORZOLAMIDE HYDROCHLORIDE
Strength
EQ 2% BASE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AT
Application
ANDA 215660
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DORZOLAMIDE HYDROCHLORIDE
- 1994TRUSOPTBrand (NDA)
NDA 020408 · MSD SUB MERCK
- 2025DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 215004 · SOMERSET THERAPS LLC
- 2019DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 204778 · MICRO LABS
- 2019DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 212639 · ALEMBIC
- 2019DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 205294 · FDC LTD
- 2014DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 202053 · REGCON HOLDINGS
- 2013DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 091034 · ZAMBON SPA
- 2009DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 079186 · AM REGENT
- 2009DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 090143 · BAUSCH AND LOMB
- 2009DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 078981 · SANDOZ
- 2008DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 078756 · TEVA PHARMS
- 2008DORZOLAMIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 078748 · SANDOZ
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
